BofA Securities raised the price target for the Ambev S.A. (NYSE:ABEV) stock from ‘an Underperform’ to ‘a Neutral’. The rating was released on November 03, 2021, according to finviz. We previously noted in another research note published on October 06, 2021 by Barclays that upgraded the stock from an Equal weight to an Overweight with a price target of $3.50 for ABEV stock. The research report from Goldman has initiated the stock to Sell, with a price target set at $2.60. In their research brief published May 20, 2021, Itau BBA analysts downgraded the Ambev S.